← Evidence map

ArticleFrontiers in immunology2025

TMEM115: a promising marker for glioma immunotherapy and prognosis.

Hang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40552281